Year: 2025
Type: article
Abstract: Artificial Intelligence (AI) has emerged as a transformative tool in various fields, including pharmacy and healthcare. It enables intelligent modelling for knowledge representation, problem-solving, and decision-making. AI has played a crucial role in pharmacy, particularly in drug discovery, drug delivery formulation development, pharmacology, and hospital pharmacy. Advanced AI techniques, such as Artificial Neural Networks (ANNs), Deep Neural Networks (DNNs), and Recurrent Neural Networks (RNNs), have been extensively applied in these domains. Notably, AI-driven approaches like Quantitative Structure-Property Relationship (QSPR) and Quantitative Structure-Activity Relationship (QSAR) have demonstrated significant potential in drug discovery, while de novo design facilitates the invention of novel drug molecules with optimal properties. AI is revolutionizing healthcare research and service delivery by enabling efficient data analysis, improving disease diagnosis, advancing digital therapeutics, and personalizing treatment strategies. With its ability to predict and forecast epidemics and pandemics, AI has been successfully applied to diseases such as seasonal influenza, Zika, Ebola, Tuberculosis, and COVID-19. Technologies like deep learning, Bayesian nonparametric models, natural language processing, and wearable devices contribute significantly to clinical trial design, patient identification, and real-time monitoring. The Indian pharmaceutical sector has emerged as a global leader in generic drug and vaccine production. However, challenges persist across various stages, from early research and development to market deployment.
Author: Tirumalareddy, Nagarjuna Reddy
Language: English
Subfield: Health Informatics
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7216931991
